2004至2018年上海市核医学体外分析室间质评结果分析  

External quality assessment results of in vitro analysis of nuclear medicine from 2004 to 2018 in Shanghai

作　　者：史昕 石珂清 张锦明 刘兴党 Shi Xin;Shi Keqing;Zhang Jinming;Liu Xingdang(Department of Nuclear Medicine,Huashan Hospital,Fudan University Shanghai Nuclear Medicine Quality Control Center,Shanghai 200040,China)

机构地区：[1]复旦大学附属华山医院核医学科、上海市核医学质量控制中心,200040

出　　处：《中华核医学与分子影像杂志》2022年第8期487-490,共4页Chinese Journal of Nuclear Medicine and Molecular Imaging

摘　　要：目的分析上海市核医学质量控制(简称质控)中心体外分析室间质评结果,以进一步加强体外分析实验室的检测质控及管理。方法对2004至2018年参加上海市核医学质控中心室间质评活动的41家单位的质评结果进行回顾性汇总分析,分别计算历年所有项目[总三碘甲状腺原氨酸(TT3)、总甲状腺素(TT4)、游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)、促甲状腺激素(TSH)、甲胎蛋白(AFP)、癌胚抗原(CEA)、总前列腺特异抗原(TPSA)]总体合格率和单项指标合格率。结果2004至2018年,室间质评所有项目的总体合格率依次为84.0%(356/424)、90.1%(381/423)、94.8%(399/421)、94.8%(291/307)、96.6%(308/319)、97.2%(280/288)、96.6%(224/232)、97.8%(225/230)、98.7%(224/227)、100.0%(221/221)、99.5%(218/219)、98.6%(215/218)、99.5%(217/218)、99.5%(189/190)、100.0%(90/90);各年单项指标合格率也呈上升趋势,但仍有体外分析实验室室间质评未达"合格",检测过程中可能存在影响检测结果的潜在风险因素。结论2004至2018年上海市核医学体外分析室间质评项目合格率逐年上升,对质评结果进行分析有助于发现实验室潜在的风险,提高实验室的检测能力。Objective To analyze the results of external quality assessment(EQA)of Shanghai Nuclear Medicine Quality Control Center,in order to further strengthen the quality control and management of in vitro testing laboratories.Methods The EQA results of 41 units evaluated by Shanghai Nuclear Medicine Quality Control Center from 2004 to 2018 were summarized and retrospectively analyzed.The overall qualified rate of all items(total triiodothyronine,TT3;total thyroxine,TT4;free triiodothyronine,FT3;free thyroxine,FT4;thyroid stimulating hormone,TSH;alpha fetoprotein,AFP;carcinoembryonic antigen,CEA;total prostate specific antigen,TPSA)and the qualified rate of singe item over the years were calculated respectively.Results From 2004 to 2018,the overall qualified rates of all items of the laboratories were 84.0%(356/424),90.1%(381/423),94.8%(399/421),94.8%(291/307),96.6%(308/319),97.2%(280/288),96.6%(224/232),97.8%(225/230),98.7%(224/227),100.0%(221/221),99.5%(218/219),98.6%(215/218),99.5%(217/218),99.5%(189/190),100.0%(90/90),respectively;and the qualified rate of singe item showed an upward trend,but there were still some laboratories′EAQ results did not reach"qualified",and there may be potential risk factors affecting the test results during the test process.Conclusions The qualified rates of in vitro testing laboratories evaluated by Shanghai Nuclear Medicine Quality Control Center show an upward trend from 2004 to 2018.Analyzing the EQA results can help to find the potential risks in the laboratory and improve the detection ability.

关 键 词：临床实验室技术 质量控制 核医学 上海 

分 类 号：R197.6[医药卫生—卫生事业管理]